PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study
Moskowitz, Alison J, Dr, Schöder, Heiko, Prof, Yahalom, Joachim, Prof, McCall, Susan J, NP, Fox, Stephanie Y, BS, Gerecitano, John, MD, Grewal, Ravinder, MD, Hamlin, Paul A, MD, Horwitz, Steven, MD, Kobos, Rachel, MD, Kumar, Anita, MD, Matasar, Matthew, MD, Noy, Ariela, MD, Palomba, M Lia, MD, Perales, Miguel-Angel, MD, Portlock, Carol S, Prof, Sauter, Craig, MD, Shukla, Neerav, MD, Steinherz, Peter, Prof, Straus, David, Prof, Trippett, Tanya, MD, Younes, Anas, Prof, Zelenetz, Andrew, Prof, Moskowitz, Craig H, Prof
Published in The lancet oncology (01.03.2015)
Published in The lancet oncology (01.03.2015)
Get full text
Journal Article
Phase II Study of Bendamustine in Relapsed and Refractory Hodgkin Lymphoma
MOSKOWITZ, Alison J, HAMLIN, Paul A, GRAUSTEIN, Tricia, ZELENETZ, Andrew D, MOSKOWITZ, Craig H, PERALES, Miguel-Angel, GERECITANO, John, HORWITZ, Steven M, MATASAR, Matthew J, NOY, Ariela, LIA PALOMBA, Maria, PORTLOCK, Carol S, STRAUS, David J
Published in Journal of clinical oncology (01.02.2013)
Published in Journal of clinical oncology (01.02.2013)
Get full text
Journal Article
Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
Moskowitz, Alison J., Schöder, Heiko, Gavane, Somali, Thoren, Katie L., Fleisher, Martin, Yahalom, Joachim, McCall, Susan J., Cadzin, Briana R., Fox, Stephanie Y., Gerecitano, John, Grewal, Ravinder, Hamlin, Paul A., Horwitz, Steven M., Kumar, Anita, Matasar, Matthew, Ni, Andy, Noy, Ariela, Palomba, M. Lia, Perales, Miguel-Angel, Portlock, Carol S., Sauter, Craig, Straus, David, Younes, Anas, Zelenetz, Andrew D., Moskowitz, Craig H.
Published in Blood (16.11.2017)
Published in Blood (16.11.2017)
Get full text
Journal Article
Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma
MOSKOWITZ, Craig H, SCHÖDER, Heiko, HORWITZ, Steven, WEAVER, Sarah A, MEIKLE, Jessica L, FILIPPA, Daniel A, CARAVELLI, James F, HAMLIN, Paul A, ZELENETZ, Andrew D, TERUYA-FELDSTEIN, Julie, SIMA, Camelia, IASONOS, Alexia, PORTLOCK, Carol S, STRAUS, David, NOY, Ariela, PALOMBA, Maria L, O'CONNOR, Owen A
Published in Journal of clinical oncology (10.04.2010)
Published in Journal of clinical oncology (10.04.2010)
Get full text
Journal Article
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL
Sauter, Craig S., Matasar, Matthew J., Schoder, Heiko, Devlin, Sean M., Drullinsky, Pamela, Gerecitano, John, Kumar, Anita, Noy, Ariela, Palomba, Maria L., Portlock, Carol S., Straus, David J., Zelenetz, Andrew D., McCall, Susan J., Miller, Shoshana T., Courtien, Amanda I., Younes, Anas, Moskowitz, Craig H.
Published in Blood (19.04.2018)
Published in Blood (19.04.2018)
Get full text
Journal Article
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
Borchmann, Sven, Joffe, Erel, Moskowitz, Craig H., Zelenetz, Andrew D., Noy, Ariela, Portlock, Carol S., Gerecitano, John F., Batlevi, Connie L., Caron, Philip C., Drullinsky, Pamela, Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Owens, Colette N., Palomba, M. Lia, Younes, Anas, Straus, David J.
Published in Blood (16.05.2019)
Published in Blood (16.05.2019)
Get full text
Journal Article
Long-Term Outcomes and Patterns of Relapse of Early-Stage Extranodal Marginal Zone Lymphoma Treated With Radiation Therapy With Curative Intent
Teckie, Sewit, MD, Qi, Shunan, MD, Lovie, Shona, MPH, Navarrett, Scott, BS, Hsu, Meier, MS, Noy, Ariela, MD, Portlock, Carol, MD, Yahalom, Joachim, MD
Published in International journal of radiation oncology, biology, physics (01.05.2015)
Published in International journal of radiation oncology, biology, physics (01.05.2015)
Get full text
Journal Article
Very low utility of surveillance imaging in early‐stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy
Gandikota, Neetha, Hartridge‐Lambert, Sidonie, Migliacci, Jocelyn C., Yahalom, Joachim, Portlock, Carol S., Schöder, Heiko
Published in Cancer (15.06.2015)
Published in Cancer (15.06.2015)
Get full text
Journal Article
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
Kumar, Anita, Casulo, Carla, Yahalom, Joachim, Schöder, Heiko, Barr, Paul M., Caron, Philip, Chiu, April, Constine, Louis S., Drullinsky, Pamela, Friedberg, Jonathan W., Gerecitano, John F., Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Jacob, Alexandra G., Matasar, Matthew J., McArthur, Gianna N., McCall, Susan J., Moskowitz, Alison J., Noy, Ariela, Palomba, Maria L., Portlock, Carol S., Straus, David J., VanderEls, Nicholas, Verwys, Stephanie L., Yang, Joanna, Younes, Anas, Zelenetz, Andrew D., Zhang, Zhigang, Moskowitz, Craig H.
Published in Blood (15.09.2016)
Published in Blood (15.09.2016)
Get full text
Journal Article
ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study
Strati, Paolo, Fanale, Michelle A, Oki, Yasuhiro, Turturro, Francesco, Fayad, Luis E, Bartlett, Nancy L, Gladstone, Douglas E, Kasamon, Yvette L, Portlock, Carol S, Wilson, Wyndham H, Goy, Andre, Younes, Anas, Lee, Hun Ju
Published in Haematologica (Roma) (01.02.2019)
Published in Haematologica (Roma) (01.02.2019)
Get full text
Journal Article
Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refractory Lymphoma Reveals Marked Activity in T-Cell Malignancies
O'CONNOR, Owen A, HORWITZ, Steven, PATTERSON, Molly, SESHAN, Venkatraman E, SIROTNAK, Frank, FLEISHER, Martin, MOULD, Diane R, SAUNDERS, Mike, ZELENETZ, Andrew D, HAMLIN, Paul, PORTLOCK, Carol, MOSKOWITZ, Craig H, SARASOHN, Debra, NEYLON, Ellen, MASTRELLA, Jill, HAMELERS, Rachel, MACGREGOR-CORTELLI, Barbara
Published in Journal of clinical oncology (10.09.2009)
Published in Journal of clinical oncology (10.09.2009)
Get full text
Journal Article
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease
Straus, David J., Portlock, Carol S., Qin, Jing, Myers, Jane, Zelenetz, Andrew D., Moskowitz, Craig, Noy, Ariela, Goy, André, Yahalom, Joachim
Published in Blood (01.12.2004)
Published in Blood (01.12.2004)
Get full text
Journal Article
Phase II Clinical Experience With the Novel Proteasome Inhibitor Bortezomib in Patients With Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
O'CONNOR, Owen A, WRIGHT, John, DUMETRESCU, Otila, ESSELTINE, Dixie, TREHU, Elizabeth, ADAMS, Julian, SCHENKEIN, David, ZELENETZ, Andrew D, MOSKOWITZ, Craig, MUZZY, Jamie, MACGREGOR-CORTELLI, Barbara, STUBBLEFIELD, Michael, STRAUS, David, PORTLOCK, Carol, HAMLIN, Paul, CHOI, Elizabeth
Published in Journal of clinical oncology (01.02.2005)
Published in Journal of clinical oncology (01.02.2005)
Get full text
Journal Article
Hepatitis C and non-Hodgkin lymphoma: The clinical perspective
Hartridge-Lambert, Sidonie K., Stein, Eytan M., Markowitz, Arnold J., Portlock, Carol S.
Published in Hepatology (Baltimore, Md.) (01.02.2012)
Published in Hepatology (Baltimore, Md.) (01.02.2012)
Get full text
Journal Article
Humidified high-flow nasal oxygen utilization in patients with cancer at Memorial Sloan-Kettering Cancer Center
Epstein, Andrew S, Hartridge-Lambert, Sidonie K, Ramaker, Judson S, Voigt, Louis P, Portlock, Carol S
Published in Journal of palliative medicine (01.07.2011)
Published in Journal of palliative medicine (01.07.2011)
Get more information
Journal Article
Clinical Experience With Intravenous and Oral Formulations of the Novel Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Patients With Advanced Hematologic Malignancies
O'CONNOR, Owen A, HEANEY, Mark L, ZELENETZ, Andrew D, FRANKEL, Stanley, RICHON, Victoria, MARKS, Paul, KELLY, William K, SCHWARTZ, Lawrence, RICHARDSON, Stacie, WILLIM, Robert, MACGREGOR-CORTELLI, Barbara, CURLY, Tracey, MOSKOWITZ, Craig, PORTLOCK, Carol, HORWITZ, Steven
Published in Journal of clinical oncology (01.01.2006)
Published in Journal of clinical oncology (01.01.2006)
Get full text
Journal Article
A genome-wide association study of marginal zone lymphoma shows association to the HLA region
Vijai, Joseph, Wang, Zhaoming, Berndt, Sonja I, Skibola, Christine F, Slager, Susan L, de Sanjose, Silvia, Melbye, Mads, Glimelius, Bengt, Bracci, Paige M, Conde, Lucia, Birmann, Brenda M, Wang, Sophia S, Brooks-Wilson, Angela R, Lan, Qing, de Bakker, Paul I W, Vermeulen, Roel C H, Portlock, Carol, Ansell, Stephen M, Link, Brian K, Riby, Jacques, North, Kari E, Gu, Jian, Hjalgrim, Henrik, Cozen, Wendy, Becker, Nikolaus, Teras, Lauren R, Spinelli, John J, Turner, Jenny, Zhang, Yawei, Purdue, Mark P, Giles, Graham G, Kelly, Rachel S, Zeleniuch-Jacquotte, Anne, Ennas, Maria Grazia, Monnereau, Alain, Bertrand, Kimberly A, Albanes, Demetrius, Lightfoot, Tracy, Yeager, Meredith, Chung, Charles C, Burdett, Laurie, Hutchinson, Amy, Lawrence, Charles, Montalvan, Rebecca, Liang, Liming, Huang, Jinyan, Ma, Baoshan, Villano, Danylo J, Maria, Ann, Corines, Marina, Novak, Anne J, Dogan, Ahmet, Liebow, Mark, Thompson, Carrie A, Witzig, Thomas E, Habermann, Thomas M, Weiner, George J, Smith, Martyn T, Holly, Elizabeth A, Jackson, Rebecca D, Tinker, Lesley F, Ye, Yuanqing, Adami, Hans-Olov, Smedby, Karin E, De Roos, Anneclaire J, Hartge, Patricia, Morton, Lindsay M, Severson, Richard K, Benavente, Yolanda, Boffetta, Paolo, Brennan, Paul, Maynadie, Marc, McKay, James, Staines, Anthony, Diver, W Ryan, Vajdic, Claire M, Armstrong, Bruce K, Kricker, Anne, Zheng, Tongzhang, Holford, Theodore R, Severi, Gianluca, Vineis, Paolo, Ferri, Giovanni M, Ricco, Rosalia, Miligi, Lucia, Clavel, Jacqueline, Giovannucci, Edward, Kraft, Peter, Virtamo, Jarmo, Smith, Alex, Kane, Eleanor, Roman, Eve, Chiu, Brian C H, Fraumeni, Joseph F, Wu, Xifeng, Cerhan, James R, Offit, Kenneth, Chanock, Stephen J, Rothman, Nathaniel, Nieters, Alexandra
Published in Nature communications (08.01.2015)
Published in Nature communications (08.01.2015)
Get full text
Journal Article
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
Kewalramani, Tarun, Zelenetz, Andrew D., Nimer, Stephen D., Portlock, Carol, Straus, David, Noy, Ariela, O'Connor, Owen, Filippa, Daniel A., Teruya-Feldstein, Julie, Gencarelli, Alison, Qin, Jing, Waxman, Alyson, Yahalom, Joachim, Moskowitz, Craig H.
Published in Blood (15.05.2004)
Published in Blood (15.05.2004)
Get full text
Journal Article
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Soumerai, Jacob D, Zelenetz, Andrew D, Moskowitz, Craig H, Palomba, M Lia, Hamlin, Jr, Paul A, Noy, Ariela, Straus, David J, Moskowitz, Alison J, Younes, Anas, Matasar, Matthew J, Horwitz, Steven M, Portlock, Carol S, Konner, Jason A, Gounder, Mrinal M, Hyman, David M, Voss, Martin H, Fury, Matthew G, Gajria, Devika, Carvajal, Richard D, Ho, Alan L, Beumer, Jan H, Kiesel, Brian, Zhang, Zhigang, Chen, Alice, Little, Richard F, Jarjies, Christine, Dang, Thu O, France, Fallon, Mishra, Nishant, Gerecitano, John F
Published in Clinical cancer research (01.08.2017)
Published in Clinical cancer research (01.08.2017)
Get full text
Journal Article